TipRanks
Clearmind Medicine (DE:CWY1)
FRANKFURT:CWY1
Germany Market
CWY1
Clearmind Medicine
RESEARCH TOOLSreports

Clearmind Medicine (CWY1) Income Statement

― Followers

Clearmind Medicine Income Statement

Last quarter (Q3 2026), Clearmind Medicine's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Clearmind Medicine's net income was C$-907.29K. See Clearmind Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 25Oct 24Oct 23Jan 23Jan 22
Total Revenue
$ 0.00$ 0.00$ 0.00C$ 0.00C$ 0.00
Gross Profit
$ -49.36K$ -51.07K$ -57.43KC$ -119.62KC$ -2.53K
Operating Expenses
$ 5.62M$ 5.69M$ 6.24MC$ 8.88MC$ 3.61M
Depreciation and Amortization
$ 49.36K$ 51.07K$ 57.51KC$ 112.98K-
EBITDA
$ -3.72M$ -4.79M$ -8.53MC$ -9.75M-
Operating Income
$ -5.67M$ -5.74M$ -6.29MC$ -9.00MC$ -3.61M
Other Income/Expenses
$ 1.88M$ 868.21K-C$ -883.54KC$ -42.78K
Pretax Income
$ -3.79M$ -4.88M$ -8.59MC$ -9.89MC$ -3.66M
Net Income
$ -3.86M$ -5.25M$ -8.61MC$ -9.93MC$ -3.66M
Per Share Metrics
Basic EPS
$ -24.24$ -54.24$ -1.36KC$ -7.33KC$ -3.78K
Diluted EPS
$ -24.24$ -54.24$ -1.36KC$ -7.33KC$ -3.78K
Weighted Average Shares Outstanding
 158.87K 96.88K 6.33K 1.35K 966.00
Weighted Average Shares Outstanding (Diluted)
 158.87K 96.88K 6.33K 1.35K 966.00

Clearmind Medicine Earnings and Revenue History